LON:IBT International Biotechnology (IBT) Share Price, News & Analysis GBX 586 -2.00 (-0.34%) As of 11:47 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About International Biotechnology Stock (LON:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBT alerts:Sign Up Key Stats Today's Range 584.88▼ 593.2850-Day Range 550▼ 63252-Week Range 480▼ 736Volume50,107 shsAverage Volume80,460 shsMarket Capitalization£210.50 millionP/E Ratio5.59Dividend Yield4.95%Price TargetN/AConsensus RatingN/A Company Overview The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments. Read More Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesIntuitive BioTechnologies has Expanded Testing CapabilitiesFebruary 6, 2025 | tmcnet.comUpstream Bio, two other U.S. biotech startups price IPOs as healthcare listings riseOctober 11, 2024 | reuters.comThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.July 1 at 2:00 AM | Weiss Ratings (Ad)Oxford BioDynamics Plc (OBD.L) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comPresentation at the 2024 International HBV Meeting Highlights Antiviral Activity of EBT-107 as a Potential Anti-HBV TherapySeptember 17, 2024 | markets.businessinsider.comUK firms fear tougher employment regulation, CBI saysSeptember 16, 2024 | reuters.comSan Jacinto College announces innovative biotechnology program to grow talent pipelineSeptember 16, 2024 | bizjournals.comBirmingham deemed “global leader in AI-driven biotech” by government officialSeptember 10, 2024 | bizjournals.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? International Biotechnology's stock was trading at GBX 682 at the start of the year. Since then, IBT shares have decreased by 14.1% and is now trading at GBX 586. View the best growth stocks for 2025 here. How were International Biotechnology's earnings last quarter? International Biotechnology (LON:IBT) announced its quarterly earnings results on Tuesday, May, 13th. The company reported ($5.60) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%. How do I buy shares of International Biotechnology? Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of International Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP). Company Calendar Last Earnings5/13/2025Today7/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:IBT CIKN/A Webwww.ibtplc.com Phone44 20 7421 7070FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 104.80 Trailing P/E Ratio5.59 Forward P/E Ratio621.03 P/E GrowthN/ANet Income£37.91 million Net Margins90.66% Pretax MarginN/A Return on Equity13.67% Return on Assets3.57% Debt Debt-to-Equity Ratio8.09 Current RatioN/A Quick Ratio0.32 Sales & Book Value Annual Sales£41.82 million Price / Sales5.03 Cash FlowGBX 3.76 per share Price / Cash Flow155.74 Book ValueGBX 766.24 per share Price / Book0.76Miscellaneous Outstanding Shares35,921,299Free FloatN/AMarket Cap£210.50 million OptionableNot Optionable Beta0.21 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (LON:IBT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.